title: p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides.
abstract: Mycosis fungoides is usually an indolent disease that, after a variable period of time in a stable phase, evolves into a tumoral form with aggressive behavior. The molecular events that mark this progression remain essentially unknown to date, and this prompted us to investigate the hypothetical role of p16(INK4a) silencing in mycosis fungoides progression. We analyzed the three most frequent mechanisms of inactivation of the p16(INK4a) gene (deletion, promoter hypermethylation, and mutation) in nine cases with patch/plaque and tumoral lesions of mycosis fungoides. The existence of alterations was investigated by microsatellite analysis, methylation-specific polymerase chain reaction, and direct sequencing. Alterations of the p16(INK4a) gene were found in four of nine of the plaque lesions (hypermethylation in three samples and allelic loss in one sample) and seven of nine in the tumor lesions (hypermethylation in five samples and allelic loss in three samples). No case presented point mutations. Although a higher incidence of p16(INK4a) hypermethylation was observed in the cases that failed to achieve a complete remission, the limited size of our series prompted us to evaluate this finding cautiously. The results of this study therefore showed a common genetic alteration that is found more frequently in tumoral lesions than it is in plaque lesions of mycosis fungoides. It also offers data that could suggest a relationship between p16(INK4a) hypermethylation and unfavorable clinical outcome. Broader studies are needed to confirm both relationships.
authors.affiliation: Departments of Genetics, Virgen de la Salud Hospital, Toledo, Spain.
authors.forename: I C
authors.initials: IC
authors.lastname: Navas
authors.forename: P L
authors.initials: PL
authors.lastname: Ortiz-Romero
authors.forename: R
authors.initials: R
authors.lastname: Villuendas
authors.forename: P
authors.initials: P
authors.lastname: Martínez
authors.forename: C
authors.initials: C
authors.lastname: García
authors.forename: E
authors.initials: E
authors.lastname: Gómez
authors.forename: J L
authors.initials: JL
authors.lastname: Rodriguez
authors.forename: D
authors.initials: D
authors.lastname: García
authors.forename: F
authors.initials: F
authors.lastname: Vanaclocha
authors.forename: L
authors.initials: L
authors.lastname: Iglesias
authors.forename: M A
authors.initials: MA
authors.lastname: Piris
authors.forename: P
authors.initials: P
authors.lastname: Algara
mesh_terms: D000328:Adult; D000368:Aged; D001483:Base Sequence; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D018899:CpG Islands; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004247:DNA / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D019175:DNA Methylation; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D019656:Loss of Heterozygosity; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D009154:Mutation; D009182:Mycosis Fungoides / Q000235:genetics* / Q000473:pathology; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology
chemical_list: D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004247:DNA